ES2060290T3 - Composiciones de acidos grasos esenciales (efa) y terapia. - Google Patents
Composiciones de acidos grasos esenciales (efa) y terapia.Info
- Publication number
- ES2060290T3 ES2060290T3 ES91300234T ES91300234T ES2060290T3 ES 2060290 T3 ES2060290 T3 ES 2060290T3 ES 91300234 T ES91300234 T ES 91300234T ES 91300234 T ES91300234 T ES 91300234T ES 2060290 T3 ES2060290 T3 ES 2060290T3
- Authority
- ES
- Spain
- Prior art keywords
- efa
- therapy
- compositions
- fatty acids
- essential fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
UN COMPUESTO FARMACEUTICO DE GLA O DGLA Y SELENIO BIODISPONIBLE, OPCIONALMENTE TAMBIEN CON UN 18: 4 O MAYOR N-3 EFA Y/O DE ZINC BIODISPONIBLE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909001121A GB9001121D0 (en) | 1990-01-18 | 1990-01-18 | Efa compositions and therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2060290T3 true ES2060290T3 (es) | 1994-11-16 |
Family
ID=10669492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91300234T Expired - Lifetime ES2060290T3 (es) | 1990-01-18 | 1991-01-14 | Composiciones de acidos grasos esenciales (efa) y terapia. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5116624A (es) |
EP (1) | EP0440341B1 (es) |
JP (1) | JP3008213B2 (es) |
AT (1) | ATE98125T1 (es) |
AU (1) | AU638525B2 (es) |
CA (1) | CA2033823C (es) |
DE (1) | DE69100724T2 (es) |
DK (1) | DK0440341T3 (es) |
ES (1) | ES2060290T3 (es) |
GB (1) | GB9001121D0 (es) |
HK (1) | HK74994A (es) |
IE (1) | IE67622B1 (es) |
NZ (1) | NZ236744A (es) |
ZA (1) | ZA91183B (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
US5407957A (en) * | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
GB9111900D0 (en) * | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
GB9112052D0 (en) * | 1991-06-05 | 1991-07-24 | Efamol Holdings | Fatty acid treatment |
BR9305932A (pt) * | 1992-02-19 | 1997-08-26 | Colby Corp Ltd | Processo para enfrentar e proporcionar resistência a eczema à intoxicação por micotoxina e à sindrome de definharnento de alces em animais processo para tratamento de eczerna de intoxicação por micotoxina e de doença de definnarnento de alces em animais composição de consistência fluida ou pastosa bolo para emprego no tratamento de eczema intoxicação por micotoxina e de sindrome de definhamento de alces composição e processo para tratamento de disturbios que reagem à administração de zinco e composição |
US20050027004A1 (en) * | 1993-06-09 | 2005-02-03 | Martek Biosciences Corporation | Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions |
GB9403855D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
ES2151277T3 (es) * | 1996-05-22 | 2000-12-16 | Protarga Inc | Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere. |
KR100657642B1 (ko) * | 1996-10-11 | 2006-12-19 | 스카리스타 리미티드 | 에이코사펜타엔산 및/또는 스테아리돈산을 포함하여 이루어지는 오일 |
AU7222598A (en) * | 1997-04-29 | 1998-11-24 | Scotia Holdings Plc | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants |
US6197764B1 (en) | 1997-11-26 | 2001-03-06 | Protarga, Inc. | Clozapine compositions and uses thereof |
US6225444B1 (en) | 1998-02-10 | 2001-05-01 | Protarga, Inc. | Neuroprotective peptides and uses thereof |
FR2774596B1 (fr) * | 1998-02-11 | 2000-03-17 | Rhone Poulenc Rorer Sa | Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer |
US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
US6258846B1 (en) * | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
US7112609B2 (en) * | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
FR2816211B1 (fr) * | 2000-11-08 | 2005-04-01 | Brif | Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses |
JP4634694B2 (ja) * | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
WO2002076402A2 (en) * | 2001-03-23 | 2002-10-03 | Protarga, Inc. | Fatty amine drug conjugates |
US20040076695A1 (en) | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
DE10305138A1 (de) * | 2003-02-07 | 2004-08-26 | Axxima Pharmaceuticals Ag | Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen |
US20060292217A1 (en) * | 2005-06-03 | 2006-12-28 | Schmidt Robbin D | Nutritional supplement and soft gelatin capsule delivery system |
NZ540958A (en) * | 2005-06-27 | 2007-11-30 | Agres Ltd | Veterinary formulation for injectable administration of selenomethionine for production of selenium-rich foods |
US20080004255A1 (en) * | 2005-10-14 | 2008-01-03 | Alltech, Inc. | Methods and compositions for altering cell function |
JP4753683B2 (ja) * | 2005-10-14 | 2011-08-24 | オルテック インコーポレイテッド | 細胞機能を変化させるための方法および組成物 |
US8865763B2 (en) * | 2005-10-14 | 2014-10-21 | Alltech, Inc. | Methods and compositions for altering cell function |
US8871715B2 (en) * | 2005-10-14 | 2014-10-28 | Alltech, Inc. | Use of selenium compounds, especially selenium yeasts for altering cognitive function |
US20100247679A1 (en) * | 2006-04-24 | 2010-09-30 | Alltech, Inc. | Methods and compositions for altering cell function |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
CA2704371A1 (en) * | 2007-11-01 | 2009-05-07 | Wake Forest University School Of Medicine | Compositions and methods for prevention and treatment of mammalian diseases |
WO2009133586A1 (ja) * | 2008-04-28 | 2009-11-05 | 有限会社アンティアンティ | アルツハイマー病の治療医薬 |
AU2011315532B2 (en) * | 2010-10-12 | 2015-02-05 | Vifor Sa | Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US20120252888A1 (en) * | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
JP2016023163A (ja) * | 2014-07-22 | 2016-02-08 | 出光興産株式会社 | γ−リノレン酸を含む神経細胞の酸化ストレス軽減剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1082624A (en) | 1965-02-26 | 1967-09-06 | Calmic Ltd | Improvements in or relating to therapeutically active compounds |
IE47777B1 (en) | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
US4273763A (en) * | 1978-01-23 | 1981-06-16 | Efamol Limited | Pharmaceutical and dietary compositions |
HU204199B (en) * | 1987-03-18 | 1991-12-30 | Caola Kozmetikai | Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components |
DE3778360D1 (de) * | 1987-07-09 | 1992-05-21 | Pierre Moreau | Oligo-elementen reiche zusammensetzungen und ihre herstellungsverfahren. |
-
1990
- 1990-01-18 GB GB909001121A patent/GB9001121D0/en active Pending
-
1991
- 1991-01-08 IE IE5091A patent/IE67622B1/en not_active IP Right Cessation
- 1991-01-09 CA CA002033823A patent/CA2033823C/en not_active Expired - Fee Related
- 1991-01-09 ZA ZA91183A patent/ZA91183B/xx unknown
- 1991-01-09 US US07/638,998 patent/US5116624A/en not_active Expired - Lifetime
- 1991-01-10 AU AU69256/91A patent/AU638525B2/en not_active Ceased
- 1991-01-11 NZ NZ236744A patent/NZ236744A/xx unknown
- 1991-01-14 ES ES91300234T patent/ES2060290T3/es not_active Expired - Lifetime
- 1991-01-14 AT AT91300234T patent/ATE98125T1/de not_active IP Right Cessation
- 1991-01-14 EP EP91300234A patent/EP0440341B1/en not_active Expired - Lifetime
- 1991-01-14 DE DE91300234T patent/DE69100724T2/de not_active Expired - Fee Related
- 1991-01-14 DK DK91300234.1T patent/DK0440341T3/da active
- 1991-01-17 JP JP3003937A patent/JP3008213B2/ja not_active Expired - Fee Related
-
1994
- 1994-07-28 HK HK74994A patent/HK74994A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69100724D1 (de) | 1994-01-20 |
JPH0733655A (ja) | 1995-02-03 |
JP3008213B2 (ja) | 2000-02-14 |
DE69100724T2 (de) | 1994-04-28 |
IE67622B1 (en) | 1996-04-17 |
NZ236744A (en) | 1993-03-26 |
CA2033823C (en) | 2002-04-09 |
AU6925691A (en) | 1991-07-25 |
DK0440341T3 (da) | 1994-02-14 |
IE910050A1 (en) | 1991-07-31 |
ZA91183B (en) | 1991-10-30 |
CA2033823A1 (en) | 1991-07-19 |
EP0440341B1 (en) | 1993-12-08 |
AU638525B2 (en) | 1993-07-01 |
US5116624A (en) | 1992-05-26 |
EP0440341A1 (en) | 1991-08-07 |
ATE98125T1 (de) | 1993-12-15 |
HK74994A (en) | 1994-08-05 |
GB9001121D0 (en) | 1990-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2060290T3 (es) | Composiciones de acidos grasos esenciales (efa) y terapia. | |
GB8319073D0 (en) | Fatty acid compositions | |
DE3868886D1 (de) | Fettsaeure-zusammensetzungen. | |
AU1821888A (en) | Treatment or prevention of memory loss using essential fatty acid compositions | |
AU4466693A (en) | Fatty acid treatment | |
AU2206188A (en) | Azithromycin and derivatives as antiprotozoal agents | |
ES2053990T3 (es) | Composiciones de acidos grasos esenciales. | |
EG20191A (en) | Novel 3,3'- dithobis (propionic acids) and esters thereof | |
DE3484606D1 (en) | Deodorant. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 440341 Country of ref document: ES |